Medicine
Hetlioz LQ 4 mg/mL oral suspension
Hetlioz LQ 4 mg/mL oral suspension is a prescription medicine containing Tasimelteon for oral use, marketed by Vanda Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
HETLIOZ LQ Oral Suspension Store HETLIOZ LQ oral suspension at refrigerated…
Key facts
- Active ingredient (INN)
- Tasimelteon
- Brand
- Hetlioz LQ
- Strength
- 4 mg/mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- Vanda Pharmaceuticals
- Manufacturer
- Vanda Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- HETLIOZ LQ Oral Suspension Store HETLIOZ LQ oral suspension at refrigerated temperature 5°C (41°F), excursions permitted to 2°C to 8°C (36°F t o 46°F). Store HETLIOZ capsules at controlled room temperature, 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from exposure to light and moisture.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05CH03 Tasimelteon
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 December 2020
- Identifiers
- RxCUI 1490473, 1491624, 2468312 +1DailyMed set ID ca4a9b63-708e-49e9-8f9b-010625443b90NDC 43068-304Application NDA214517
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 48 mL in 1 bottle | 43068-304-02 | Vanda Pharmaceuticals | 10 December 2020 |
| 1 bottle in 1 carton / 158 mL in 1 bottle | 43068-304-06 | Vanda Pharmaceuticals | 10 December 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tasimelteon
Clinical summary
Tasimelteon is a melatonin receptor agonist indicated for the treatment of non-24-Hour Sleep-Wake Disorder (Non-24) in adults, among other approved uses. It is available as capsules and oral suspension. MedsAcross supplies Tasimelteon for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TasimelteonFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Hetlioz prescribing information (Vanda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Hetlioz: European public assessment report (EPAR) · European Medicines Agency
Need Hetlioz LQ 4 mg/mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.